Friday, January 11, 2013
Vevey, Switzerland, January 2013 – Exclusive enteral nutrition in paediatric Crohn’s disease is a highly effective, well-tolerated, anti-inflammatory treatment and contributes to mucosal healing according to experts at the recent Nestlé Nutrition Institute symposium at the 4th World Congress of Paediatric Gastroenterology, Hepatology and Nutrition (WCPGHAN) held in Taipei (Taiwan). Speakers emphasised the importance of meticulous attention to the nutritional needs of young patients with inflammatory bowel disease (IBD) as a way of improving long-term disease outcomes and not just treating the inflammatory component of the disease.
The worldwide incidence and burden of Crohn’s disease and ulcerative colitis is rising with studies showing that it is twice as common compared with ulcerative colitis in the paediatric age group. The impact of Crohn’s disease on pubertal development can be devastating, manifesting as micro-nutrient deficiencies, inadequate macro-nutrients, weight loss and impaired growth. The Nestlé Nutrition Institute brought together experts in paediatric Crohn’s disease to discuss Nutritional Novelties in the Management of Paediatric Crohn’s Disease.
The key role for Enteral Nutrition as Prevalence of Paediatric Crohn’s Disease increases -
(1) Exclusive enteral nutrition is an effective and well-tolerated treatment in paediatric Crohn’s disease
(2) Nutritional support is a crucial part of the management of Crohn’s disease to optimise disease control and improve long-term outcomes
(3) Nutritional therapy improves long-term bone health.
To get the complete information of the congress -
Click here !